Abstract
Rheumatoid arthritis (RA) is an inflammatory disease that primarily involves the joints and has a worldwide prevalence of about one percent, with a female to male ratio of 3:1. This chapter summarizes some of the recent progress in molecular immunology, and discusses the application of this new knowledge for therapeutic purposes. We focus on our recent experiences and that of others in modulation of antigen specific responses as a tool for manipulating autoimmune inflammation. Particular emphasis is given to the concept of exploiting for therapeutic purposes a natural mechanism of immune regulation. This mechanism is based on sequential cross recognition of bacterial and human derived heat shock protein peptides.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 8 April 2003; accepted by W. B. van den Berg 8 April 2003
Rights and permissions
About this article
Cite this article
Puga Yung, G.L., Le, T.D., Roord, S. et al. Heat shock proteins (HSP) for immunotherapy of rheumatoid arthritis (RA). Inflamm. res. 52, 443–451 (2003). https://doi.org/10.1007/s00011-003-1204-6
Issue Date:
DOI: https://doi.org/10.1007/s00011-003-1204-6